A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2004
12/01/2004	CN1177847C Oxazolidines compounds as 5-HT2A-antagonists
12/01/2004	CN1177844C Cyclopropanes as CGRP antagonists, medicaments contg. said compounds and method for production thereof
12/01/2004	CN1177843C Novel chalcones
12/01/2004	CN1177842C New agarofuran derivatives and their prepn. medicine composition and use as medicine
12/01/2004	CN1177834C Dihydroxyhexanoic acid derivatives
12/01/2004	CN1177833C Substd. quinazoline derivatives
12/01/2004	CN1177832C Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
12/01/2004	CN1177831C New benzimidazolone-benzoxazolone-, or benzothiazoloe derivatives as ion channel modulating agents
12/01/2004	CN1177830C Benzoheterocycles and their use as MEK inhibitors
12/01/2004	CN1177829C Substituted sulphonyl cyanamides, method for producing same and their use as medicament
12/01/2004	CN1177828C Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
12/01/2004	CN1177827C Biphenylsulfonyl-substd. imidazole derivs., their preparation process, their use as drug or diagnostic agent and drug contg. them
12/01/2004	CN1177825C Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use thereof as medicaments
12/01/2004	CN1177821C Matrix metalloprotease inhibitors
12/01/2004	CN1177808C Solid compositions suitable for oral administration composing L-carnitine and alkanoyl-L-carnitine mangesium tartrate
12/01/2004	CN1177805C Method for reducnig 2-dimethylamio-2-phenylpropion-acid ethyl ester content in solutions of 2-dimethylamino-1-phenyl-3-cyclohexene-1- carboxylic acid ethy ester
12/01/2004	CN1177616C Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods of use thereof
12/01/2004	CN1177615C Arteriovenous and venous graft treatment methods and compsns.
12/01/2004	CN1177614C Slow releasing composition
12/01/2004	CN1177610C Pharmaceutical composition for immunomodulation based on peptides and adjuvants
12/01/2004	CN1177608C Preparation of erosion of cervix
12/01/2004	CN1177599C Chinese medicine for treating burn and scald and its preparing process
12/01/2004	CN1177594C Formulation for use in prevention of pathogen induced diseases including HIV and HSV
12/01/2004	CN1177593C Fructan containing compsn. for prevention and treatment of colon cancer
12/01/2004	CN1177592C Use of manyinflorescenced sweetvetch extract total saponin in preparing myocarditis treating medicine
12/01/2004	CN1177591C Medicaments that contain xenogenic oligo-or/and polyribonucleotides
12/01/2004	CN1177590C Cyclophosphamide coated tablets
12/01/2004	CN1177589C Analgesic combination
12/01/2004	CN1177588C Coated dosage unit
12/01/2004	CN1177587C Riluzole and alpha-tocopherol combination
12/01/2004	CN1177586C Use of pramipexole as nerveprotective agent
12/01/2004	CN1177583C Formulations for parenteral use of estramustine phosphate with improved pharmacological properties
12/01/2004	CN1177581C Aqueous aerosol preparations containing biologically active macromolecules and method for producing the corresponding aerosols
12/01/2004	CN1177580C Phytosterol copmositions and their application
12/01/2004	CN1177579C Skin and hair preparations
11/2004
11/30/2004	US6826033 Beta 3 adrenergic receptor agonists; treatment of pollakiuria, urinary incontinence, obesity or diabetes
11/30/2004	US6825365 Intermediates for the hemisynthesis of taxanes and preparation processes therefor
11/30/2004	US6825360 Bicyclic aromatic compounds
11/30/2004	US6825355 For therapy of immunologic disorders such as transplant rejection, rheumatoid arthritis. multiple sclerosis, inflammatory bowel disease, lupus, graft vs. host disease
11/30/2004	US6825353 Process for producing quinolonecarboxylic acids and intermediates thereof
11/30/2004	US6825350 Administering dosage of immunology response moderator
11/30/2004	US6825349 Purine derivatives for treatment of gastrointestinal disorders, immunological disorders, neurological disorders
11/30/2004	US6825345 Reacting 7-amino-3-vinylceph-3-em-4-carboxylic acid with 2-(2-amino-4-thiazolyl-2(aryl or alkyl)oxycarbonylmethyoxy-iminoacetylthio-)benzothiazole to obtain cefixime; salt formation with tert-octylamine; crystal structure
11/30/2004	US6825331 Aminooxy functionalized oligomers, oligomer arrays and methods of using them
11/30/2004	US6825329 Human PEM as a target for birth control and treatment of Alzheimer's disease
11/30/2004	US6825326 Antibody which specifically binds to prostate stem cell antigen on surface of carcinoma cells and is internalized within carcinoma cells to which it binds
11/30/2004	US6825321 For breeding cold-avoidance plants; treatment of diabetes metllitus/obesity; development of thermogenic bio-materials
11/30/2004	US6825317 Histone deacetylase inhibitor, a major histocompatibility complex class-i molecule expression-promoting agent and anticancer agents
11/30/2004	US6825234 Compositions and methods for amelioration of human female sexual dysfunction
11/30/2004	US6825232 Use of hydroxyeicosatetraenoic acid compounds to treat ophthalmic inflammatory disorders
11/30/2004	US6825231 Substituted norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and a medicament comprising them
11/30/2004	US6825230 Spiro and dispiro 1,2,4-trixolane antimalarials
11/30/2004	US6825229 Administering protein kinase c activators such as macrocyclic lactones (i.e. bryostatin class and neristatin class)
11/30/2004	US6825228 To treat infections by gram-positive bacteria, in particular drug- resistant strains
11/30/2004	US6825226 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias
11/30/2004	US6825225 Bicyclic isoxazolinones as antibacterial agents
11/30/2004	US6825224 Prodrugs of carbamate inhibitors of IMPDH
11/30/2004	US6825223 Anilide compounds and pharmaceutical compositions comprising them
11/30/2004	US6825222 Modulators of peroxisome proliferator activated receptors
11/30/2004	US6825221 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
11/30/2004	US6825220 3-Substituted oxindole β 3 agonists
11/30/2004	US6825219 Substituted benzimidazole compounds
11/30/2004	US6825218 Encapsulated crystal form for oral suspensions without bad taste
11/30/2004	US6825217 Heterocyclic amines such as 4-(3'-thienyl)-alpha, alpha, 1-trimethyl-4-piperidinemethanol and/or prodrugs, used as analgesics for prophylaxis of neuropathic pain
11/30/2004	US6825216 Alkenylene piperidine amide, which can be isolated from piper nigrum
11/30/2004	US6825214 Substantially pure cilostazol and processes for making same
11/30/2004	US6825213 β3-adrenoreceptor agonists, agonist compositions and methods of using
11/30/2004	US6825212 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands
11/30/2004	US6825210 5,10-dihydrobenzo(b)(1,8)naphthyridine compounds, n-oxides; 3,7-dichloro-5-isopropoxymethyl-5-trifluoromethyl-5,10 -dihydrobenzo(b)(1,8)naphthyridine for example; combination therapy
11/30/2004	US6825207 Anticancer agents
11/30/2004	US6825206 Treatment of leukemia, solid tumors and brain glioma in mammals using the conjugates
11/30/2004	US6825205 N-substituted hydromorphones and the use thereof
11/30/2004	US6825204 N-substituted 3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
11/30/2004	US6825203 Topical anesthetic/opioid formulations and uses thereof
11/30/2004	US6825202 Central nervous system disorders; psychological disorders
11/30/2004	US6825201 Indole, azaindole and related heterocyclic amidopiperazine derivatives
11/30/2004	US6825200 Substituted dipeptides having nos inhibiting activity
11/30/2004	US6825198 5-HT receptor ligands and uses thereof
11/30/2004	US6825197 Cyclic GMP-specific phosphodiesterase inhibitors
11/30/2004	US6825194 Hexacyclic compounds
11/30/2004	US6825193 Heterocyclic amines such as 4-(3,4-dichlorophenyl)-2-(2-(4-methylpiperazin-1-yl)-benzylidene) -thiomorpholin-3-one, used as antiserotonine agents
11/30/2004	US6825192 Non-n-methyl-d-aspartate (non- nmda) excitatory amino acid receptor antagonistic action, for example 2-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (ampa) receptor antagonistic action
11/30/2004	US6825191 Benzodiazepine derivatives
11/30/2004	US6825190 Protein kinase inhibitors and uses thereof
11/30/2004	US6825189 Treating withdrawal symptoms caused by smoking cessation
11/30/2004	US6825188 More potent inhibitors of the vitronectin receptor than the fibrinogen
11/30/2004	US6825186 Method and compositions for treating atheroma, tumors and other neoplastic tissue
11/30/2004	US6825185 Improving the cardiovascular profile of a cox-2 selective inhibitor by administering with 3-hydroxy-3- methylglutaryl coenzyme a, an antiplatelet agent, a thrombin inhibitor or a thromboxane inhibitor
11/30/2004	US6825184 For use as anti-inflammatory agents
11/30/2004	US6825182 For postmenopausal substitution therapy of gynecological diseases, such as hysteromyomas or dysmenorrhoic symptoms
11/30/2004	US6825179 Active ingredient combinations or adducts of cyclodextrins and quinones
11/30/2004	US6825177 2',3'-didehydro-3'-deoxythymidine (d4t); extending the elimination half-life of d4t metabolite in a mammal administering said derivative; treating human immunodeficiency virus (hiv)
11/30/2004	US6825174 Mixture of surfactant and nucleic acids
11/30/2004	US6825173 Preparation of fagopyritols and uses therefor
11/30/2004	US6825172 3-descladinosyl-6-O-carbamoyl and 6-O-carbonoyl macrolide antibacterial agents
11/30/2004	US6825170 Erythromycin type macrolide with a fused oxazolone ring
11/30/2004	US6825166 Molecular conjugates for use in treatment of cancer
11/30/2004	US6825015 Process for the obtaining of HMG-COA reductase inhibitors of high purity
11/30/2004	US6825007 Therapeutic and diagnostic methods and compositions based on Jagged/Notch proteins and nucleic acids
11/30/2004	US6824978 Regulation of endogenous gene expression in cells using zinc finger proteins

1 ... 4876 4877 4878 4879 4880 4881 4882 4883 4884 4885 4886 4887 4888 4889 4890 4891 4892 4893 4894 4895 4896 ... 7860